Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881

Homeostatic plasticity in the developing nervous system

Turrigiano, G. G., & Nelson, S. B. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1327 · Cited by 2,485

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses

Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926

The brain reward circuitry in mood disorders

Russo, S. J., & Nestler, E. J. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3381 · Cited by 1,870

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793

Neurocircuitry of Mood Disorders

Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606 · cited 1×

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260

Prefrontal cortex and depression

Pizzagalli, D. A., & Roberts, A. C. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01101-7 · Cited by 667

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

Yang, C., Shirayama, Y., Zhang, J.-C., Ren, Q., Yao, W., Ma, M., Dong, C., & Hashimoto, K. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.136 · Cited by 605

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

Vargas, M. V., Dunlap, L. E., Dong, C., Carter, S. J., Tombari, R. J., Jami, S. A., Cameron, L. P., Patel, S. D., Hennessey, J. J., Saeger, H. N., et al. (2023) · Science · doi:10.1126/science.adf0435 · Cited by 519

Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions

Hare, B. D., & Duman, R. S. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0685-9 · Cited by 366

GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions

Gerhard, D. M., Pothula, S., Liu, R.-J., Wu, M., Li, X.-Y., Girgenti, M. J., Taylor, S. R., Duman, C. H., Delpire, E., Picciotto, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130808 · Cited by 345

Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective

Hashimoto, K. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12902 · Cited by 335

Role of BDNF in the Pathophysiology and Treatment of Depression: Activity-Dependent Effects Distinguish Rapid-Acting Antidepressants

Duman, R. S., Deyama, S., & Fogaça, M. V. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14630 · Cited by 321

Prefrontal excitatory/inhibitory balance in stress and emotional disorders: Evidence for over-inhibition

Page, C. E., & Coutellier, L. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.07.024 · Cited by 213

Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects

Hare, B. D., Shinohara, R., Liu, R. J., Pothula, S., DiLeone, R. J., & Duman, R. S. (2019) · Nature Communications · doi:10.1038/s41467-018-08168-9 · Cited by 217

Brain NMDA Receptors in Schizophrenia and Depression

Adell, A. (2020) · Biomolecules · doi:10.3390/biom10060947 · Cited by 225

KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS

Abdallah, C. G., Adams, T. G., Kelmendi, B., Esterlis, I., Sanacora, G., & Krystal, J. H. (2016) · Depression and Anxiety · doi:10.1002/da.22501 · Cited by 206

Fast-acting antidepressant activity of ketamine: Highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies

Pham, T. H., & Gardier, A. M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.017 · Cited by 186

Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2 R ,6 R )-hydroxynorketamine

Fukumoto, K., Fogaça, M. V., Liu, R.-J., Duman, C., Kato, T., Li, X.-Y., & Duman, R. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814709116 · Cited by 188

Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors

Berardis, D. D., Fornaro, M., Valchera, A., Cavuto, M., Perna, G., Nicola, M. D., Serafini, G., Carano, A., Pompili, M., Vellante, F., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102888 · Cited by 179

Convergent Mechanisms Underlying Rapid Antidepressant Action

Zanos, P., Thompson, S. M., Duman, R. S., Zarate, C. A., & Gould, T. D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0492-x · Cited by 171

Chronic, Intermittent Microdoses of the Psychedelic N , N -Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents

Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00692 · Cited by 168

Psychedelics and Other Psychoplastogens for Treating Mental Illness.

Vargas, M. V., Meyer, R., Avanes, A. A., Rus, M., & Olson, D. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.727117 · Cited by 166

Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function

Duman, R. S., Shinohara, R., Fogaça, M. V., & Hare, B. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0400-x · Cited by 157

Longitudinal Effects of Ketamine on Dendritic Architecture In Vivo in the Mouse Medial Frontal Cortex

Phoumthipphavong, V., Barthas, F., Hassett, S., & Kwan, A. C. (2016) · eneuro · doi:10.1523/eneuro.0133-15.2016 · Cited by 132

Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms

Kohtala, S. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00232-4 · Cited by 155

Laminar and Cellular Distribution of Monoamine Receptors in Rat Medial Prefrontal Cortex

Santana, N., & Artigas, F. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00087 · Cited by 135

Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses

Fogaça, M. V., Wu, M., Li, C., Li, X.-Y., Picciotto, M. R., & Duman, R. S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00916-y · Cited by 129

SIRT1 in forebrain excitatory neurons produces sexually dimorphic effects on depression-related behaviors and modulates neuronal excitability and synaptic transmission in the medial prefrontal cortex

Lei, Y., Wang, J., Wang, D., Li, C., Liu, B., Fang, X., You, J., Guo, M., & Lu, X.-Y. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0352-1 · Cited by 131

Ketamine accelerates fear extinction via mTORC1 signaling

Girgenti, M. J., Ghosal, S., Lopresto, D., Taylor, J. R., & Duman, R. S. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.026 · Cited by 125

Sensitivity of the prefrontal GABAergic system to chronic stress in male and female mice: Relevance for sex differences in stress-related disorders

Shepard, R., Page, C. E., & Coutellier, L. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.038 · Cited by 118

Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors

Navarria, A., Wohleb, E. S., Voleti, B., Ota, K. T., Dutheil, S., Lepack, A. E., Dwyer, J. M., Fuchikami, M., Becker, A., Drago, F., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.012 · Cited by 118

Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1

Zhang, K., Yang, C., Chang, L., Sakamoto, A., Suzuki, T., Fujita, Y., Qu, Y., Wang, S., Pu, Y., Tan, Y., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0733-x · Cited by 119

The molecular pathophysiology of depression and the new therapeutics

Tian, H., Hu, Z., Xu, J., & Wang, C. (2022) · MedComm · doi:10.1002/mco2.156 · Cited by 122

Ketamine: Mechanisms and Relevance to Treatment of Depression

Kim, J., Suzuki, K., Kavalali, E. T., & Monteggia, L. M. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-051322-120608 · Cited by 131

Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine

Shirayama, Y., & Hashimoto, K. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx108 · Cited by 113

GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine

Liu, R.-J., Duman, C., Kato, T., Hare, B., Lopresto, D., Bang, E., Burgdorf, J., Moskal, J., Taylor, J., Aghajanian, G., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.202 · Cited by 105

Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine

Deyama, S., Bang, E., Wohleb, E. S., Li, X., KATO, T., Gerhard, D. M., Dutheil, S., Dwyer, J. M., Taylor, S. R., Picciotto, M. R., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17121368 · Cited by 99

Ketamine rapidly reverses stress-induced impairments in GABAergic transmission in the prefrontal cortex in male rodents

Ghosal, S., Duman, C. H., Liu, R.-J., Wu, M., Terwilliger, R., Girgenti, M. J., Wohleb, E., Fogaca, M. V., Teichman, E. M., Hare, B., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104669 · Cited by 89

Ventral CA3 Activation Mediates Prophylactic Ketamine Efficacy Against Stress-Induced Depressive-like Behavior

Mastrodonato, A., Martinez, R., Pavlova, I. P., LaGamma, C. T., Brachman, R. A., Robison, A. J., & Denny, C. A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.011 · Cited by 95

Ketamine Rapidly Enhances Glutamate-Evoked Dendritic Spinogenesis in Medial Prefrontal Cortex Through Dopaminergic Mechanisms

Wu, M., Minkowicz, S., Dumrongprechachan, V., Hamilton, P., & Kozorovitskiy, Y. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.022 · Cited by 95

Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine

Fukumoto, K., Iijima, M., Funakoshi, T., & Chaki, S. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx116 · Cited by 93

Perspectives for therapy of treatment‐resistant depression

Papp, M., Cubała, W. J., Święcicki, Ł., Newman‐Tancredi, A., & Willner, P. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15596 · Cited by 96

BDNF Release and Signaling Are Required for the Antidepressant Actions of GLYX-13

Kato, T., Fogaça, M. V., Deyama, S., Li, X.-Y., Fukumoto, K., & Duman, R. S. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.220 · Cited by 88

Infralimbic cortex is required for learning alternatives to prelimbic promoted associations through reciprocal connectivity

Mukherjee, A., & Caroni, P. (2018) · Nature Communications · doi:10.1038/s41467-018-05318-x · Cited by 95

Glutamine has antidepressive effects through increments of glutamate and glutamine levels and glutamatergic activity in the medial prefrontal cortex

Son, H., Baek, J. H., Go, B. S., Jung, D.-H., Sontakke, S. B., Chung, H. J., Lee, D. H., Roh, G. S., Kang, S. S., Cho, G. J., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.040 · Cited by 89

Sex Differences in Risk and Resilience: Stress Effects on the Neural Substrates of Emotion and Motivation

Wellman, C. L., Bangasser, D. A., Bollinger, J. L., Coutellier, L., Logrip, M. L., Moench, K. M., & Urban, K. R. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1673-18.2018 · Cited by 88

Functional Contribution of the Medial Prefrontal Circuitry in Major Depressive Disorder and Stress-Induced Depressive-Like Behaviors

Bittar, T. P., & Labonté, B. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.699592 · Cited by 87

Orphan receptor GPR158 controls stress-induced depression

Sutton, L. P., Orlandi, C., Song, C., Oh, W. C., Muntean, B. S., Xie, K., Filippini, A., Xie, X., Satterfield, R., Yaeger, J. D. W., et al. (2018) · eLife · doi:10.7554/elife.33273 · Cited by 88

Infralimbic prefrontal cortex structural and functional connectivity with the limbic forebrain: a combined viral genetic and optogenetic analysis

Wood, M., Adil, O., Wallace, T., Fourman, S. M., Wilson, S. P., Herman, J. P., & Myers, B. (2018) · Brain Structure and Function · doi:10.1007/s00429-018-1762-6 · Cited by 90

Cell-type specific modulation of NMDA receptors triggers antidepressant actions

Pothula, S., KATO, T., Liu, R.-J., Wu, M., Gerhard, D. M., Shinohara, R., Sliby, A., Chowdhury, G. M. I., Behar, K. L., Sanacora, G., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0796-3 · Cited by 82

The anterior cingulate cortex as a key locus of ketamine’s antidepressant action

Alexander, L., Jelen, L. A., Mehta, M. A., & Young, A. H. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.003 · Cited by 83

Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine

López-Gil, X., Jiménez-Sánchez, L., Campa, L., Castro, E., Frago, C., & Adell, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00288 · Cited by 80

Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis

Bruno, A., Dolcetti, E., Rizzo, F. R., Fresegna, D., Musella, A., Gentile, A., Vito, F. D., Caioli, S., Guadalupi, L., Bullitta, S., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00169 · Cited by 87

Previous Ketamine Produces an Enduring Blockade of Neurochemical and Behavioral Effects of Uncontrollable Stress

Amat, J., Dolzani, S. D., Tilden, S. G., Christianson, J. P., Kubala, K. H., Bartholomay, K. L., Sperr, K., Ciancio, N., Watkins, L. R., & Maier, S. F. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3114-15.2016 · Cited by 85

Stress‐induced structural and functional modifications of astrocytes—Further implicating glia in the central response to stress

Murphy‐Royal, C., Gordon, G. R., & Bains, J. S. (2019) · Glia · doi:10.1002/glia.23610 · Cited by 80

Astrocyte dysfunction drives abnormal resting-state functional connectivity in depression

Liu, J., Mo, J., Wang, X., An, Z., Zhang, S., Zhang, C.-Y., Yi, P., Leong, A. T. L., Ren, J., Chen, L.-Y., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo2098 · Cited by 76

Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments

Krystal, J. H., Kaye, A. P., Jefferson, S., Girgenti, M. J., Wilkinson, S. T., Sanacora, G., & Esterlis, I. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305772120 · Cited by 83

Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression

Shirayama, Y., & Hashimoto, K. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0718-1 · Cited by 75

Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors

da Rosa, P. B., Neis, V. B., Ribeiro, C. M., Moretti, M., & Rodrigues, A. L. S. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.05.010 · Cited by 76

Optogenetic and chemogenetic insights into the neurocircuitry of depression‐like behaviour: A systematic review

Biselli, T., Lange, S. S., Sablottny, L., Steffen, J., & Walther, A. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14603 · Cited by 77

Antidepressant effects of ketamine on depression-related phenotypes and dopamine dysfunction in rodent models of stress

Rincón‐Cortés, M., & Grace, A. A. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112367 · Cited by 72

Therapeutic mechanisms of psychedelics and entactogens

Heifets, B. D., & Olson, D. E. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01666-5 · Cited by 70

Synaptic Regulation of a Thalamocortical Circuit Controls Depression-Related Behavior

Miller, O. H., Bruns, A., Ammar, I. B., Mueggler, T., & Hall, B. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.002 · Cited by 69

Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in mice

Fullana, M. N., Ruiz‐Bronchal, E., Ferrés‐Coy, A., Juárez‐Escoto, E., Artigas, F., & Bortolozzi, A. A. (2019) · Glia · doi:10.1002/glia.23593 · Cited by 73

Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms

Hare, B. D., Ghosal, S., & Duman, R. S. (2017) · Chronic Stress · doi:10.1177/2470547017697317 · Cited by 67

Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment

Johnston, J. N., Kadriu, B., Allen, J., Gilbert, J. R., Henter, I. D., & Zarate, C. A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109422 · Cited by 73

Depression and substance use disorders: Clinical comorbidity and shared neurobiology

Calarco, C. A., & Lobo, M. K. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.004 · Cited by 74

Macro- and Microscale Stress–Associated Alterations in Brain Structure: Translational Link With Depression

Banasr, M., Sanacora, G., & Esterlis, I. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.004 · Cited by 71

A Focus on the Functions of Area 25

Alexander, L., Clarke, H. F., & Roberts, A. (2019) · Brain Science · doi:10.3390/brainsci9060129 · Cited by 54

SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like action

Erburu, M. M., Muñoz-Cobo, I., Diaz-Perdigón, T., Mellini, P., Suzuki, T., Puerta, E., & Tordera, R. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.033 · Cited by 64

Bridging Rapid and Sustained Antidepressant Effects of Ketamine

Kim, J.-W., Suzuki, K., Kavalali, E. T., & Monteggia, L. M. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.02.003 · Cited by 59

Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats

Gasull-Camós, J., Tarrés-Gatius, M., Artigas, F., & Castañé, A. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.7 · Cited by 64

Corticotropin-releasing hormone neurons control trigeminal neuralgia-induced anxiodepression via a hippocampus-to-prefrontal circuit

Lv, S., Lv, X., Cai, Y.-Q., Hou, X.-Y., Zhang, Z.-Z., Wang, G., Chen, L., Lü, N., & Zhang, Y. (2024) · Science Advances · doi:10.1126/sciadv.adj4196 · Cited by 65

Serial Prefrontal Pathways Are Positioned to Balance Cognition and Emotion in Primates

Joyce, M. K. P., García‐Cabezas, M. Á., John, Y. J., & Barbas, H. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0860-20.2020 · Cited by 61

Rodent ketamine depression-related research: Finding patterns in a literature of variability

Polis, A. J., Fitzgerald, P. J., Hale, P. J., & Watson, B. O. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112153 · Cited by 63

Cortical functional hyperconnectivity in a mouse model of depression and selective network effects of ketamine

McGirr, A., LeDue, J. M., Chan, A. W., Xie, Y., & Murphy, T. H. (2017) · Brain · doi:10.1093/brain/awx142 · Cited by 60

Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy

Zorumski, C. F., Nagele, P., Mennerick, S., & Conway, C. R. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00172 · Cited by 57

Astrocyte control of glutamatergic activity: Downstream effects on serotonergic function and emotional behavior

Fullana, M. N., Gasull-Camós, J., Tarrés-Gatius, M., Castañé, A., Bortolozzi, A. A., & Artigas, F. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107914 · Cited by 58

Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?

Zhao, F., Cheng, Z., Piao, J., Cui, R., & Li, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.947785 · Cited by 64

The role of serotonin in depression—A historical roundup and future directions

Bremshey, S., Groß, J., Renken, K., & Masseck, O. A. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16097 · Cited by 66

Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation

Fukumoto, K., Fogaça, M. V., Liu, R.-J., Duman, C. H., Li, X., Chaki, S., & Duman, R. S. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0705-0 · Cited by 58

Neurobiology of the rapid-acting antidepressant effects of ketamine: impact and opportunities

Shinohara, R., Aghajanian, G. K., & Abdallah, C. G. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.006 · Cited by 54

Synergistic effects of two naturally occurring iridoids in eliciting a rapid antidepressant action by up‐regulating hippocampal PACAP signalling

Zhang, H., Sun, Y., Yau, S., Zhou, Y., Song, X., Zhang, H., Zhu, B., Wu, H., & Chen, G. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15847 · Cited by 52

Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant

Xu, S., Yao, X., Li, B., Cui, R., Zhu, C., Wang, Y., & Yang, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.740996 · Cited by 53

Attenuated dopamine signaling after aversive learning is restored by ketamine to rescue escape actions

Wu, M., Minkowicz, S., Dumrongprechachan, V., Hamilton, P., Xiao, L., & Kozorovitskiy, Y. (2021) · eLife · doi:10.7554/elife.64041 · Cited by 54

Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model

Zhang, K., Fujita, Y., & Hashimoto, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-22449-9 · Cited by 50

Inhibition of a Descending Prefrontal Circuit Prevents Ketamine-Induced Stress Resilience in Females

Dolzani, S. D., Baratta, M. V., Moss, J. R., Leslie, N. L., Tilden, S. G., Sørensen, A. T., Watkins, L. R., Lin, Y., & Maier, S. F. (2018) · eNeuro · doi:10.1523/eneuro.0025-18.2018 · Cited by 52

Posterior Orbitofrontal and Anterior Cingulate Pathways to the Amygdala Target Inhibitory and Excitatory Systems with Opposite Functions

Zikopoulos, B., Höistad, M., John, Y. J., & Barbas, H. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3940-16.2017 · Cited by 50

Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms

KATO, T., & Duman, R. S. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172827 · Cited by 49

M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington’s disease

Fernández‐García, S., Conde-Berriozabal, S., García-García, E., Gort‐Paniello, C., Bernal‐Casas, D., Barriga, G. G.-D., López-Gil, X., Muñoz‐Moreno, E., Sòria, G., Campa, L., et al. (2020) · eLife · doi:10.7554/elife.57017 · Cited by 45

The role of the excitation:inhibition functional balance in the mPFC in the onset of antidepressants

Yin, Y., Wang, Y., Liu, W., Yao, J.-Q., Yuan, J., Li, Z.-H., Ran, Y., Zhang, L., & Li, Y. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108573 · Cited by 51

Time is of the essence: Coupling sleep-wake and circadian neurobiology to the antidepressant effects of ketamine

Kohtala, S., Alitalo, O., Rosenholm, M., Rozov, S. V., & Rantamäki, T. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107741 · Cited by 47

Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants

Wang, Y., Zhang, N., Liu, L., Jiang, H., Hu, D., Wang, Z., Chen, N., & Zhang, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.024 · Cited by 50

The ventromedial prefrontal cortex and emotion regulation: lost in translation?

Alexander, L., Wood, C. M., & Roberts, A. (2022) · The Journal of Physiology · doi:10.1113/jp282627 · Cited by 48

Ketamine activated glutamatergic neurotransmission by GABAergic disinhibition in the medial prefrontal cortex

Zhang, B., Yang, X., Ye, L., Liu, R., Ye, B., Du, W., Shen, F., Li, Q., Guo, F., Liu, J., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108382 · Cited by 47

VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine

Jiang, C., Lin, W.-J., Labonté, B., Tamminga, C. A., Turecki, G., Nestler, E. J., Russo, S. J., & Salton, S. R. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0277-4 · Cited by 43

An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine

Berardis, D. D., Tomasetti, C., Pompili, M., Serafini, G., Vellante, F., Fornaro, M., Valchera, A., Perna, G., Volpe, U., Martinotti, G., et al. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200131100316 · Cited by 46

Social defeat stress causes selective attenuation of neuronal activity in the ventromedial prefrontal cortex

Abe, R., Okada, S., Nakayama, R., Ikegaya, Y., & Sasaki, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-45833-5 · Cited by 47

In vivo knockdown of astroglial glutamate transporters GLT-1 and GLAST increases excitatory neurotransmission in mouse infralimbic cortex: Relevance for depressive-like phenotypes

Fullana, M. N., Covelo, A., Bortolozzi, A. A., Araque, A., & Artigas, F. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.004 · Cited by 46

Cortical–Hypothalamic Integration of Autonomic and Endocrine Stress Responses

Schaeuble, D., & Myers, B. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.820398 · Cited by 50

Ultrasound Stimulation of Prefrontal Cortex Improves Lipopolysaccharide-Induced Depressive-Like Behaviors in Mice

Yi, S., Zou, J., Meng, L., Chen, H.-M., Hong, Z.-Q., Liu, X., Farooq, U., Chen, M.-X., Lin, Z., Zhou, W., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.864481 · Cited by 44

Behavioral Animal Models and Neural-Circuit Framework of Depressive Disorder

Tian, X., Russo, S. J., & Li, L. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01270-7 · Cited by 49

Infralimbic medial prefrontal cortex signalling to calbindin 1 positive neurons in posterior basolateral amygdala suppresses anxiety- and depression-like behaviours

Yu, H., Chen, L., Lei, H., Pi, G., Xiong, R., Jiang, T., Wu, D., Sun, F., Gao, Y., Li, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33139-6 · Cited by 46

Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition

Lüscher, B., Feng, M., & Jefferson, S. J. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.03.002 · Cited by 41

Optogenetic Stimulation of Drd1 Expressing Neurons Produces Rapid and Long-Lasting Antidepressant EffectsPreprint

Hare, B. D., Liu, R. J., Shinohara, R., Pothula, S., Dileone, R., & Duman, R. S. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155673

Optogenetic stimulation of medial prefrontal cortex Drd1 neurons produces rapid and long-lasting antidepressant effects

Hare, B. D., Shinohara, R., Liu, R. J., Pothula, S., DiLeone, R. J., & Duman, R. S. (2019) · Nature Communications · doi:10.1038/s41467-018-08168-9 · Cited by 217

Distinct downstream targets of the medial prefrontal cortex underlie discrete antidepressant responses to ketamine

Shinohara, R., Hare, B. D., Liu, R.-J., Li, J. H., Li, X., Duman, C. H., Dileone, R., & Duman, R. S. (2022) · Proceedings for Annual Meeting of The Japanese Pharmacological Society · doi:10.1254/jpssuppl.95.0_1-o-011

Activation of a ventral hippocampus–medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine

Carreno, F. R., Donegan, J. J., Boley, A. M., Shah, A., DeGuzman, M., Frazer, A., & Lodge, D. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.176 · Cited by 205

Planar cell polarity proteins mediate ketamine-induced restoration of glutamatergic synapses in prefrontal cortical neurons in a mouse model for chronic stress

Freitas, A. E., Feng, B., Woo, T., Galli, S., Baker, C., Ban, Y., Truong, J., Beyeler, A., & Zou, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-48257-6 · Cited by 9